skip to main content

Palivizumab Criteria — RACP Paediatrics MCQ

Instant feedback + full explanation. One question, done properly.

ModerateRespiratoryPalivizumab CriteriaRACP Paediatrics

A 6-month-old premature infant (born at 28 weeks) is about to enter the winter RSV season. He has chronic lung disease and is still on home oxygen. Is he eligible for palivizumab prophylaxis?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Yes – he meets criteria for palivizumab prophylaxis

Palivizumab eligibility in Australia includes infants <12 months corrected age with chronic lung disease requiring ongoing oxygen or respiratory support, and infants with haemodynamically significant CHD. It is given monthly during the RSV season (typically May-October in southeastern Australia).

Reference: RCH Melbourne – 2024 – Clinical Practice Guidelines: RSV Prophylaxis